- Results for your query on May 26, 1999
- Search all fields for: Crataegus And heart disease
- Published in 1966 through 1999
- Only select references with abstracts available
- Show references published in English only
- Show references pertaining to humans
Documents: 1 to 10 of 10
NLM database Documents
Record 1 from database: MEDLINE
Return To Top
- Title
- Botanical influences on cardiovascular disease.
- Author
- Miller AL
- Address
- Alternative Medicine Review. P.O. Box 25, Dover, ID 83825, USA. alan@thorne.com
- Source
- Altern Med Rev, 1998 Dec, 3:6, 422-31
- Abstract
- Several botanicals, including Crataegus oxycantha, Terminalia arjuna, Inula racemosa, and Astragalus membranaceus, have been found to have therapeutic benefit for the treatment of cardiovascular disease. Crataegus oxycantha has been used traditionally as a cardiac tonic and current uses include treatment for angina, hypertension, arrhythmias, and congestive heart failure. Animal studies have also indicated that Crataegus extracts may also have potential use as anti-ischemic and lipid-lowering agents. The bark of the Terminalia arjuna tree has a long history of use as a cardiac tonic as well, and has been indicated in the treatment of coronary artery disease, heart failure, hypercholesterolemia and for relief of anginal pain. Additionally, it has been found to have antibacterial and antimutagenic properties. Inula racemosa, also known as Pushkarmoola, is another traditional Ayurvedic botanical that has potential cardioprotective benefit. In human trials, a combination of Inula racemosa and Commiphora mukul was shown to be superior to nitroglycerin in reducing the chest pain and dyspnea associated with angina. Astragalus membranaceus, a Chinese herb, is often used as a "Qi tonifier" and has been studied for its therapeutic benefit in treatment of ischemic heart disease, myocardial infarction, heart failure, and relief of anginal pain. Clinical studies have indicated that its in vitro antioxidant activity is the mechanism by which it affords its cardioprotective benefit.
- Language of Publication
- English
- Unique Identifier
- 99072930
- MeSH Heading (Major)
- Bioflavonoids|*TU; Cardiovascular Diseases|*TH; Plants, Medicinal|*TU
- MeSH Heading
- Antioxidants|TU; Heart Failure, Congestive|TH; Human; Medicine, Ayurvedic; Myocardial Ischemia|TH; Plant Extracts|TU
- Publication Type
- JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
- ISSN
- 1089-5159
- Country of Publication
- UNITED STATES
- CAS Registry/EC Number
- 0 (Antioxidants); 0 (Bioflavonoids); 0 (Plant Extracts)
Record 2 from database: MEDLINE
Return To Top
- Title
- Nutritional control of heart disease and cancer: are different diets necessary.
- Author
- Crawford MA
- Address
- Source
- Nutr Health, 1985, 4:1, 7-15
- Abstract
- Man evolved as a wild animal and his nutritional biology was adapted to wild plants and animals. That diets have been modified by trade is illustrated from the author's experience in Uganda where dramatic differences occur in the diets in the North and South of the country. Internationally, the incidence and pattern both of cardiovascular disease and cancer caries with the ecology of the regions. What is seen in miniature in Uganda is to be seen enlarged upon a world scale. In the course of agriculture we have changed the balance of nutrients offered by wild plants and animals. In particular we have substituted storage fat for structural fat whilst also changing our diet in the direction of a high refined carbohydrate food structure.
- Language of Publication
- English
- Unique Identifier
- 86204451
- MeSH Heading (Major)
- Diet|*/AE; Heart Diseases|*ET/PC; Neoplasms|*ET/PC
- MeSH Heading
- Adult; Animal; Bladder Neoplasms|ET; Cattle; Child, Preschool; Comparative Study; Dietary Fats|AE; Female; Human; Indoles|AE; Infant; Japan; Liver Neoplasms|ET; Plants, Medicinal; Uganda; United States
- Publication Type
- JOURNAL ARTICLE
- ISSN
- 0260-1060
- Country of Publication
- ENGLAND
Record 3 from database: MEDLINE
Return To Top
- Title
- Alternatives to hormone replacement for menopause [see comments]
- Author
- Soffa VM
- Address
- Breast Cancer Action Group, Burlington, Vt, USA.
- Source
- Altern Ther Health Med, 1996 Mar, 2:2, 34-9
- Abstract
- This paper examines the controversy over estrogen therapies and shows how lifestyle interventions can be offered as a safe way to promote prevention and good health, without the risks and long-term side effects associated with hormone replacement drugs. Some researchers show that estrogen therapy may decrease osteoporosis and heart disease. Preventing these diseases has become the primary justification for recommending hormones to most menopausal women, whether the loss of estrogen is induced by surgical removal of the ovaries, hysterectomy, ovary radiation, chemotherapy, or is a result of the natural aging process. Prevention is the foremost reason that many clinicians tell their patients that the benefits outweigh the risks, and the reason women are advised to use this therapy for decades. More women may be requesting alternatives to the widely prescribed hormone replacement drugs as concern about the long-term risks and public understanding about the drug-free options for prevention grow. Beginning with providing information about the risks associated with both estrogen and the combination of estrogen and progestogen, this paper examines "natural" approaches to conditions commonly associated with menopause.
- Language of Publication
- English
- Unique Identifier
- 96388484
- MeSH Heading (Major)
- Estrogen Replacement Therapy|*/AE; Menopause|*
- MeSH Heading
- Breast Neoplasms; Female; Food, Fortified; Heart Diseases; Human; Osteoporosis|PC; Plants, Medicinal
- Publication Type
- JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
- ISSN
- 1078-6791
- Country of Publication
- UNITED STATES
Record 4 from database: MEDLINE
Return To Top
- Title
- Certain progress in the treatment of coronary heart disease with traditional medicinal plants in China.
- Author
- Chen KJ
- Address
- Source
- Am J Chin Med, 1981 Aut, 9:3, 193-6
- Abstract
- A case of coronary heart disease in China was confirmed by the necropsy of a female body unearthed from the tomb at Changsha. It proved that such a case existed about 2,100 years ago. Research in reducing the frequency of myocardial infarction by traditional medicinal plants showed the effect of several herbs. The traditional aromatic and warm herbal medicines may have the possibility of relieving coronary arterial spasm. The clinical and experimental observations proved that the Huoxue-huayu plants' action against blood platelet aggregation and against attack was effective.
- Language of Publication
- English
- Unique Identifier
- 83253043
- MeSH Heading (Major)
- Coronary Disease|*DT/HI/MO; Medicine, Chinese Traditional|*; Medicine, Oriental Traditional|*; Plants, Medicinal|*
- MeSH Heading
- Animal; Cyclic AMP|BL; Dogs; Electrocardiography; History of Medicine, Ancient; History of Medicine, Medieval; History of Medicine, Modern; Human; Plant Extracts|TU; Platelet Aggregation|DE; Rabbits; Rats
- Publication Type
- JOURNAL ARTICLE
- ISSN
- 0192-415X
- Country of Publication
- UNITED STATES
Record 5 from database: MEDLINE
Return To Top
- Title
- Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.
- Author
- Schultze AE; Roth RA
- Address
- Department of Pathology, College of Veterinary Medicine, University of Tennessee, Knoxville, USA.
- Source
- J Toxicol Environ Health B Crit Rev, 1998 Oct, 1:4, 271-346
- Abstract
- Monocrotaline (MCT) is a toxic pyrrolizidine alkaloid of plant origin. Administration of small doses of MCT or its active metabolite, monocrotaline pyrrole (MCTP), to rats causes delayed and progressive lung injury characterized by pulmonary vascular remodeling, pulmonary hypertension, and compensatory right heart hypertrophy. The lesions induced by MCT(P) administration in rats are similar to those observed in certain chronic pulmonary vascular diseases of people. This review begins with a synopsis of the hemostatic system, emphasizing the role of endothelium since endothelial cell dysfunction likely underlies the pathogenesis of MCT(P)-induced pneumotoxicity. MCT toxicology is discussed, focusing on morphologic, pulmonary mechanical, hemodynamic, and biochemical and molecular alterations that occur after toxicant exposure. Fibrin and platelet thrombosis of the pulmonary microvasculature occurs after administration of MCT(P) to rats, and several investigators have hypothesized that thrombi contribute to the lung injury and pulmonary hypertension. The evidence for involvement of the various components of the hemostatic system in MCT(P)-induced vascular injury and remodeling is reviewed. Current evidence is consistent with involvement of platelets and an altered fibrinolytic system, yet much remains to be learned about specific events and signals in the vascular pathogenesis.
- Language of Publication
- English
- Unique Identifier
- 98450117
- MeSH Heading (Major)
- Endothelium, Vascular|*DE/PA; Hemostasis|*DE; Hypertension, Pulmonary|BL/*CI/ET; Hypertrophy, Right Ventricular|BL/*CI/ET; Monocrotaline|*AA/AE/*TO
- MeSH Heading
- Animal; Disease Models, Animal; Human; Plants, Medicinal|AE; Plants, Toxic|AE; Rats; Support, U.S. Gov't, P.H.S.
- Publication Type
- JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC
- ISSN
- 1093-7404
- Country of Publication
- UNITED STATES
Record 6 from database: MEDLINE
Return To Top
- Title
- Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.
- Author
- Schultze AE; Roth RA
- Address
- Department of Pathology, College of Veterinary Medicine, University of Tennessee, Knoxville, USA.
- Source
- J Toxicol Environ Health B Crit Rev, 1998 Oct, 1:4, 271-346
- Abstract
- Monocrotaline (MCT) is a toxic pyrrolizidine alkaloid of plant origin. Administration of small doses of MCT or its active metabolite, monocrotaline pyrrole (MCTP), to rats causes delayed and progressive lung injury characterized by pulmonary vascular remodeling, pulmonary hypertension, and compensatory right heart hypertrophy. The lesions induced by MCT(P) administration in rats are similar to those observed in certain chronic pulmonary vascular diseases of people. This review begins with a synopsis of the hemostatic system, emphasizing the role of endothelium since endothelial cell dysfunction likely underlies the pathogenesis of MCT(P)-induced pneumotoxicity. MCT toxicology is discussed, focusing on morphologic, pulmonary mechanical, hemodynamic, and biochemical and molecular alterations that occur after toxicant exposure. Fibrin and platelet thrombosis of the pulmonary microvasculature occurs after administration of MCT(P) to rats, and several investigators have hypothesized that thrombi contribute to the lung injury and pulmonary hypertension. The evidence for involvement of the various components of the hemostatic system in MCT(P)-induced vascular injury and remodeling is reviewed. Current evidence is consistent with involvement of platelets and an altered fibrinolytic system, yet much remains to be learned about specific events and signals in the vascular pathogenesis.
- Language of Publication
- English
- Unique Identifier
- 98450117
- MeSH Heading (Major)
- Endothelium, Vascular|*DE/PA; Hemostasis|*DE; Hypertension, Pulmonary|BL/*CI/ET; Hypertrophy, Right Ventricular|BL/*CI/ET; Monocrotaline|*AA/AE/*TO
- MeSH Heading
- Animal; Disease Models, Animal; Human; Plants, Medicinal|AE; Plants, Toxic|AE; Rats; Support, U.S. Gov't, P.H.S.
- Publication Type
- JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC
- ISSN
- 1093-7404
- Country of Publication
- UNITED STATES
Record 7 from database: MEDLINE
Return To Top
- Title
- A new medical trend in China.
- Author
- Li CP
- Address
- Source
- Am J Chin Med, 1975 Jul, 3:3, 213-21
- Abstract
- Chinese biomedical scientists are now developing a new approach to medicine by combining traditional Chinese medicine and Western biomedical science. This is the current medical trend in China. Some significant results have already been achieved. For instance, in treating fractures the traditional dexterity in coaxing broken ends of bones into alignment has been successfully adopted, and x-ray has been used to check whether there was accurate bone union. Heart diseases are treated with Western drugs in combination with Chinese herbal medicine, and the results are encouraging. Ancient theories such as Fu Chen Pei Ben (to strengthen the patient's vitality) are applied, for instance, in cancer therapy, i.e., to stimulate the patient's appetite and to improve his general condition with herbs while being treated with Western anti-cancer remedies. However, the Chinese admit that this process has only just begun.
- Language of Publication
- English
- Unique Identifier
- 76059091
- MeSH Heading (Major)
- Medicine|*
- MeSH Heading
- Acupuncture; Anesthesia; Appendicitis|DT; China; Drug Therapy, Combination; Fractures|TH; Ginseng; Heart Diseases|TH; Human; Hypotension|TH; Medicine, Chinese Traditional; Middle Age; Neoplasms|TH; Plants, Medicinal
- Publication Type
- JOURNAL ARTICLE
- ISSN
- 0090-2942
- Country of Publication
- UNITED STATES
Record 8 from database: MEDLINE
Return To Top
- Title
- Assessment of the adrenergic beta-blocking activity of Inula racemosa.
- Author
- Tripathi YB; Tripathi P; Upadhyay BN
- Address
- Department of Medicinal Chemistry, Banaras Hindu University, Varanasi, India.
- Source
- J Ethnopharmacol, 1988 May, 23:1, 3-9
- Abstract
- Inula racemosa root powder was investigated in patients with proven ischaemic heart disease. The powder prevented ST-segment depression and T-wave inversion as observed in the post-exercise electrocardiogram. The petroleum ether extract of roots lowered plasma insulin and glucose levels within 75 min of oral administration to albino rats and it significantly counteracted adrenaline-induced hyperglycaemia in rats. The extract further showed negative inotropic and negative chronotropic effects on frog heart. All these findings indicate that one of the constituents of Inula racemosa may have adrenergic beta-blocking activity.
- Language of Publication
- English
- Unique Identifier
- 88333890
- MeSH Heading (Major)
- Adrenergic beta-Antagonists|*TU; Coronary Disease|*DT/PP; Plants, Medicinal|*
- MeSH Heading
- Adult; Animal; Blood Glucose|ME; Evaluation Studies; Heart Rate|DE; Human; In Vitro; Insulin|BL; Middle Age; Myocardial Contraction|DE; Plant Extracts|TU; Ranidae; Rats
- Publication Type
- JOURNAL ARTICLE
- ISSN
- 0378-8741
- Country of Publication
- SWITZERLAND
Record 9 from database: MEDLINE
Return To Top
- Title
- On the ethnomedical significance of the Arjun tree, Terminalia arjuna (Roxb.) Wight & Arnot.
- Author
- Kumar DS; Prabhakar YS
- Address
- Department of Physiology, International Institute of Ayurveda, Ramanathapuram, Coimbatore, India.
- Source
- J Ethnopharmacol, 1987 Jul, 20:2, 173-90
- Abstract
- Terminalia arjuna is an important cardiotonic plant described in the Ayurveda, the ancient Indian medical science. It is also believed to have the ability to cure hepatic, urogenital, venereal and viral diseases. An attempt is made here to analyse the available drug recipes using this plant from Sanskrit literature in the light of modern scientific knowledge. The chemistry and pharmacology of T. arjuna are also discussed, and areas of future investigations are identified.
- Language of Publication
- English
- Unique Identifier
- 88012591
- MeSH Heading (Major)
- Medicine, Ayurvedic|*; Plants, Medicinal|*
- MeSH Heading
- Chemistry; Fractures|DT; Heart Diseases|DT; Human; Liver Diseases|DT; Plant Extracts|AN/TU; Skin Diseases|DT; Support, Non-U.S. Gov't; Tuberculosis, Pulmonary|DT; Urologic Diseases|DT
- Publication Type
- JOURNAL ARTICLE
- ISSN
- 0378-8741
- Country of Publication
- SWITZERLAND
Record 10 from database: MEDLINE
Return To Top
- Title
- Prevention of atheromatous heart disease.
- Author
- Agarwal OP
- Address
- Source
- Angiology, 1985 Aug, 36:8, 485-92
- Abstract
- Five thousand patients of atheromatous heart disease, presented as angina pectoris, were studied over a period of five years. After adding the 'Husk of Isabgol' and 'aloe vera' (an indigenous plant known as ghee-guar-ka-paththa) to the diet, a marked reduction in total serum cholesterol, serum triglycerides, fasting and post prandial blood sugar level in diabetic patients, total lipids and also increase in HDL were noted. Simultaneously the clinical profile of these patients showed reduction in the frequency of anginal attacks and gradually, the drugs, like verapamil, nifedipine, beta-blockers and nitrates, were tapered. The patients, most benefitted, were diabetics (without adding any antidiabetic drug). The exact mechanism of the action of the above two substances is not known, but it appears, that probably they act by their high fibre contents. Both these substances need further evaluation. The most interesting aspect of the study was that no untoward side effect was noted and all the five thousand patients are surviving till date.
- Language of Publication
- English
- Unique Identifier
- 85304965
- MeSH Heading (Major)
- Angina Pectoris|*PC; Plants, Medicinal|*
- MeSH Heading
- Adrenergic beta-Antagonists|AD; Adult; Aged; Aloe; Blood Glucose|AN; Cholesterol|BL; Diabetes Mellitus|TH; Diuretics|AD; Dose-Response Relationship, Drug; Exercise Test; Female; Follow-Up Studies; Human; Hypertension|TH; India; Isosorbide Dinitrate|AD; Lipoproteins, HDL Cholesterol|BL; Male; Middle Age; Triglycerides|BL; Verapamil|AD
- Publication Type
- JOURNAL ARTICLE
- ISSN
- 0003-3197
- Country of Publication
- UNITED STATES
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.